1. Home
  2. MRUS vs ENVA Comparison

MRUS vs ENVA Comparison

Compare MRUS & ENVA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MRUS
  • ENVA
  • Stock Information
  • Founded
  • MRUS 2003
  • ENVA 2011
  • Country
  • MRUS Netherlands
  • ENVA United States
  • Employees
  • MRUS N/A
  • ENVA N/A
  • Industry
  • MRUS Biotechnology: Pharmaceutical Preparations
  • ENVA Finance: Consumer Services
  • Sector
  • MRUS Health Care
  • ENVA Finance
  • Exchange
  • MRUS Nasdaq
  • ENVA Nasdaq
  • Market Cap
  • MRUS 2.7B
  • ENVA 2.3B
  • IPO Year
  • MRUS 2016
  • ENVA N/A
  • Fundamental
  • Price
  • MRUS $42.77
  • ENVA $94.98
  • Analyst Decision
  • MRUS Strong Buy
  • ENVA Buy
  • Analyst Count
  • MRUS 14
  • ENVA 6
  • Target Price
  • MRUS $87.00
  • ENVA $126.80
  • AVG Volume (30 Days)
  • MRUS 786.0K
  • ENVA 297.6K
  • Earning Date
  • MRUS 05-07-2025
  • ENVA 04-29-2025
  • Dividend Yield
  • MRUS N/A
  • ENVA N/A
  • EPS Growth
  • MRUS N/A
  • ENVA 52.89
  • EPS
  • MRUS N/A
  • ENVA 8.48
  • Revenue
  • MRUS $54,732,000.00
  • ENVA $1,304,376,000.00
  • Revenue This Year
  • MRUS $26.81
  • ENVA $155.12
  • Revenue Next Year
  • MRUS $23.85
  • ENVA $13.07
  • P/E Ratio
  • MRUS N/A
  • ENVA $11.25
  • Revenue Growth
  • MRUS N/A
  • ENVA 21.58
  • 52 Week Low
  • MRUS $33.19
  • ENVA $57.46
  • 52 Week High
  • MRUS $61.61
  • ENVA $117.56
  • Technical
  • Relative Strength Index (RSI)
  • MRUS 49.60
  • ENVA 51.15
  • Support Level
  • MRUS $37.92
  • ENVA $90.92
  • Resistance Level
  • MRUS $46.36
  • ENVA $95.49
  • Average True Range (ATR)
  • MRUS 2.56
  • ENVA 3.32
  • MACD
  • MRUS -0.22
  • ENVA 0.07
  • Stochastic Oscillator
  • MRUS 57.46
  • ENVA 55.77

About MRUS Merus N.V.

Merus NV is a clinical-stage immuno-oncology company. It develops bispecific antibody therapeutics. The company is developing full-length human multispecific antibody therapeutics, referred to as Biclonics. Merus has only one reportable segment comprising the discovery and development of bispecific therapeutics. Some of its products in the pipeline include MCLA-128; MCLA-117; MCLA-158 and others.

About ENVA Enova International Inc.

Enova International Inc provides online financial services, including short-term consumer loans, line of credit accounts, and installment loans to customers mainly in the United States and and Brazil. Consumers apply for credit online, the company's technology platforms process the applications, and transactions are completed quickly and efficiently. Its customers are predominantly retail consumers and small businesses. Enova markets its financing products under the names CashNetUSA, NetCredit, OnDeck, Headway Capital, and Simplic. The company also operates a money transfer platform under the name Pangea. Geographically, the company generates a majority of its revenue from its business in the United States and the rest from other international countries.

Share on Social Networks: